172 related articles for article (PubMed ID: 33996552)
21. Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Yerram P; Reiss SN; Modelevsky L; Schaff L; Reiner AS; Panageas KS; Grommes C
Ann Lymphoma; 2023 Feb; 7():. PubMed ID: 37067886
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
23. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
[TBL] [Abstract][Full Text] [Related]
25. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
[TBL] [Abstract][Full Text] [Related]
26. Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients.
Li M; Bai J; Wang S; Zhai Y; Zhang S; Li C; Du J; Zhang Y
Front Oncol; 2021; 11():548325. PubMed ID: 33718126
[TBL] [Abstract][Full Text] [Related]
27. Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.
Lolli C; Caffo O; Scarpi E; Aieta M; Conteduca V; Maines F; Bianchi E; Massari F; Veccia A; Chiuri VE; Facchini G; De Giorgi U
Front Pharmacol; 2016; 7():376. PubMed ID: 27790145
[No Abstract] [Full Text] [Related]
28. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Yang J; Xu H; Guo X; Zhang J; Ye X; Yang Y; Ma X
Sci Rep; 2018 Feb; 8(1):3044. PubMed ID: 29445100
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].
Niu JY; Zhu HY; Wang L; Fan L; Liang JH; Cao L; Wu W; Xia Y; Wu JZ; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):265-270. PubMed ID: 29779318
[No Abstract] [Full Text] [Related]
31. Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma.
Mirili C; Paydas S; Kapukaya TK; Yılmaz A
Biomark Med; 2019 Dec; 13(18):1565-1575. PubMed ID: 31631675
[No Abstract] [Full Text] [Related]
32. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Kasenda B; Ferreri AJ; Marturano E; Forst D; Bromberg J; Ghesquieres H; Ferlay C; Blay JY; Hoang-Xuan K; Pulczynski EJ; Fosså A; Okoshi Y; Chiba S; Fritsch K; Omuro A; O'Neill BP; Bairey O; Schandelmaier S; Gloy V; Bhatnagar N; Haug S; Rahner S; Batchelor TT; Illerhaus G; Briel M
Ann Oncol; 2015 Jul; 26(7):1305-13. PubMed ID: 25701456
[TBL] [Abstract][Full Text] [Related]
33. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
34. Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?
Cetin B; Berk V; Kaplan MA; Afsar B; Tufan G; Ozkan M; Isikdogan A; Benekli M; Coskun U; Buyukberber S
Clin Genitourin Cancer; 2013 Jun; 11(2):141-8. PubMed ID: 23083797
[TBL] [Abstract][Full Text] [Related]
35. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
[TBL] [Abstract][Full Text] [Related]
37. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients with Glioblastoma: A Comprehensive Study Based on Meta-Analysis and Retrospective Single-Center Analysis.
Yang C; Hu BW; Tang F; Zhang Q; Quan W; Wang J; Wang ZF; Li YR; Li ZQ
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556130
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
[TBL] [Abstract][Full Text] [Related]
40. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
